Here's Why Cardinal Health (CAH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health, Inc. (CAH) Baird's Global Healthcare Conference 2023 (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) Baird's Global Healthcare Conference 2023 September 13, 2023 8:30 AM ET Company Participants Matt Sims - Investor Relations Jason Hollar - Chief Executive Officer ...
The 3 Best Safe Stocks to Buy Now: September 2023
Summer is unofficially over, but what a difference a year makes. The S&P 500 lost 19% in 2022 yet has rallied 17% higher since the end of July.
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health's (CAH) Latest Launch to Enhance Neonatal Feeding
Cardinal Health's (CAH) latest offering is likely to help premature and newborn infants develop the oral coordination skills important for the faster transition to independent feeding.
3 Healthcare Stocks to Help Your Portfolio Get Well
Many investors continue to look for growth wherever they can find it. That makes the healthcare sector very compelling.
Cardinal Health (CAH) Q4 Earnings and Revenues Beat Estimates
Cardinal Health (CAH) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.05 per share a year ago.
Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Stree...
Cardinal Health (CAH) Beats on Q4 Earnings, Ups '24 EPS View
Cardinal Health's (CAH) fiscal fourth-quarter results benefit from the Pharmaceutical segment's solid performance.
Cardinal Health raises 2024 profit forecast on drug distribution strength
Drug distributor Cardinal Health Inc raised its 2024 profit forecast on Tuesday, as it sees strong demand for specialty and generic medicines to continue to boost sales in its pharmaceuticals unit.
Cardinal Health Beats on Earnings, Raises Guidance on Strong Pharmaceutical Sales
Cardinal Health reported fiscal fourth-quarter earnings of $1.55 a share on revenue of $53.5 billion.
Cardinal Health's stock dips premarket after company swings to a loss
Cardinal Health Inc.'s stock CAH slid 1% in premarket trade Tuesday, after the health services company swung to a loss for its fiscal fourth quarter from a profit a year ago. Dublin, Ohio-based Car...
Is a Beat Likely for Cardinal Health (CAH) in Q4 Earnings?
Cardinal Health's (CAH) fiscal fourth-quarter 2023 results are expected to reflect solid performance in the Pharmaceutical segment.
Related Companies